Logo image
Conditional survival of extremity soft-tissue sarcoma: Results beyond the staging system
Journal article   Open access

Conditional survival of extremity soft-tissue sarcoma: Results beyond the staging system

Helen M. Parsons, Elizabeth B. Habermann, Todd M. Tuttle and Waddah B. Al-Refaie
Cancer, Vol.117(5)
2011

Abstract

Adolescent Adult Aged Aged, 80 and over Amputation Extremities Female Humans Male Middle Aged Neoplasm Staging Prognosis Sarcoma SEER Program Soft Tissue Neoplasms Survival Analysis Survival Rate Young Adult adult age aged article cancer diagnosis cancer grading cancer mortality cancer size cancer surgery cancer survival controlled study female histopathology human human tissue limb amputation major clinical study male metastasis potential prediction priority journal soft tissue sarcoma survival time
BACKGROUND: With increasing interest in adult cancer survivorship, currently available prognostic estimates for long-term survivors of extremity soft-tissue sarcoma (ESTS) are limited. We assessed determinants of survival in adults surgically treated for nonmetastatic ESTS, conditional on specific survival periods. Methods: We identified 6215 persons aged >18 in the Surveillance Epidemiology and End Results program who were surgically treated for nonmetastatic ESTS from 1991 to 2006.We used Cox proportional hazards regression to assess demographic, tumor, and treatment factors associated with 10-year sarcoma-specific survival (SSS) at diagnosis and conditional on surviving 3 and 5 years postdiagnosis. RESULTS: At the time of diagnosis, age, tumor, and treatment factors predicted SSS. Although older age significantly predicted worse SSS for all age groups at diagnosis (HR 3.78 for age >81 vs 18-35; P < .05 for all), the effect of age became nonsignificant as survival time increased, except for the oldest group (>80 years). Tumor size, grade, and histologic subtypes continued to be important predictors of SSS for all periods of conditional survival. Persons who underwent limb amputation were at 3 times the risk of mortality for all conditional survival periods. CONCLUSIONS: In this large population-based experience of ESTS survivors, age >80, tumor, and treatment factors continued to affect long-term survival, whereas the effect of age dampened over time. These estimates provide important counseling information for changing risk factors as survival time increases, help to streamline future surveillance programs, and provide insights into the design of adult survivorship care. © 2010 American Cancer Society.
url
https://doi.org/10.1002/cncr.25564View
Published (Version of record) Open

Metrics

7 Record Views

Details

Logo image